This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sirnes, P. A. Articles by Sirnes, K. E. Search for Related Content PubMed PubMed Citation Articles by Sirnes, P. A. Articles by Sirnes, K. E.

Circulation, Vol 70, 638-644, Copyright © 1984 by American Heart Association

ARTICLES

Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial

PA Sirnes, K Overskeid, TR Pedersen, J Bathen, A Drivenes, GS Froland, JK Kjekshus, K Landmark, R Rokseth and KE Sirnes

In a multicenter double-blind study, 227 patients with suspected acute myocardial infarction (AMI) were randomized within 12 hr from onset of symptoms to treatment with nifedipine (112 patients) or placebo (115 patients). AMI was confirmed in 74 patients on nifedipine and in 83 on placebo. Patients with AMI received nifedipine 5.5 +/- 2.9 hr (mean +/- SD) after onset of symptoms. Infarct size was assessed by the release of creatine kinase isoenzyme MB (CK-MB). Infarct size index (CK-MB geq/m2) was 25 +/- 16 (n = 71) in the nifedipine group and 23 +/- 13 (n = 77) in the placebo group (NS). After the first 10 mg of nifedipine systolic blood pressure fell from 147 +/- 30 to 135 +/- 28 mm Hg (p less than .01) and heart rate rose from 75 +/- 18 to 79 +/- 19 beats/min (p less than .01). No change was observed after the first placebo dose. The treatment was continued for 6 weeks. Over this period there were 10 deaths in each group. Early treatment with nifedipine in patients with AMI does not seem to reduce infarct size as determined by enzyme level.

This article has been cited by other articles:

				J Abdulla, B Brendorp, C Torp-Pedersen, L Kober, and on behalf of the TRACE study group Does the electrocardiographic presence of Q waves influence the survival of patients with acute myocardial infarction? Eur. Heart J., June 2, 2001; 22(12): 1008 - 1014. [Abstract] [PDF]

				J. R. Kizer and S. E. Kimmel Epidemiologic Review of the Calcium Channel Blocker Drugs: An Up-to-date Perspective on the Proposed Hazards Arch Intern Med, May 14, 2001; 161(9): 1145 - 1158. [Abstract] [Full Text] [PDF]

				C. D. Frances, A. S. Go, K. W. Dauterman, K. Deosaransingh, D. L. Jung, S. Gettner, J. M. Newman, B. M. Massie, and W. S. Browner Outcome Following Acute Myocardial Infarction: Are Differences Among Physician Specialties the Result of Quality of Care or Case Mix? Arch Intern Med, July 12, 1999; 159(13): 1429 - 1436. [Abstract] [Full Text] [PDF]

				S. M. Zaacks, P. R. Liebson, J. E. Calvin, J. E. Parrillo, and L. W. Klein Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? J. Am. Coll. Cardiol., January 1, 1999; 33(1): 107 - 118. [Abstract] [Full Text] [PDF]

				P. Theroux, J. Gregoire, C. Chin, G. Pelletier, P. de Guise, and M. Juneau Intravenous diltiazem in acute myocardial infarction: Diltiazem as adjunctive therapy to activase (DATA) trial J. Am. Coll. Cardiol., September 1, 1998; 32(3): 620 - 628. [Abstract] [Full Text] [PDF]

				C. D. Furberg, B. M. Psaty, and J. V. Meyer Nifedipine : Dose-Related Increase in Mortality in Patients With Coronary Heart Disease Circulation, September 1, 1995; 92(5): 1326 - 1331. [Abstract] [Full Text]

				U. Goldbourt, S. Behar, H. Reicher-Reiss, M. Zion, L. Mandelzweig, and E. Kaplinsky Early Administration of Nifedipine in Suspected Acute Myocardial Infarction: The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study Arch Intern Med, February 8, 1993; 153(3): 345 - 353. [Abstract] [PDF]

				J. J. Popma and E. J. Topol Adjuncts to Thrombolysis for Myocardial Reperfusion Ann Intern Med, July 1, 1991; 115(1): 34 - 44. [Abstract] [PDF]

				A. E. Skolnick and W. H. Frishman Calcium Channel Blockers in Myocardial Infarction Arch Intern Med, July 1, 1989; 149(7): 1669 - 1677. [Abstract] [PDF]

				R. C. Becker and J. S. Alpert Beyond Coronary Thrombolysis Arch Intern Med, July 1, 1988; 148(7): 1503 - 1507. [Abstract] [PDF]

				B. W. Johansson, O. Hansen, S. Juul-Moller, and O. Svensson Adrenaline-Induced Changes in Serum Electrolytes, ECG, and Blood Pressure, with Ca-Blockade Pretreatment Angiology, April 1, 1988; 39(4): 345 - 354. [Abstract] [PDF]

				D.P. Mikhailidis, M.A. Barradas, A. Mier, F. Boag, J.Y. Jeremy, C.W.H. Havard, and P. Dandona Platelet Function in Patients Admitted with a Diagnosis of Myocardial Infarction Angiology, January 1, 1987; 38(1): 36 - 45. [Abstract] [PDF]

				Drugs Five Years Later: Nifedipine in Myocardial Ischemia, Systemic Hypertension, and Other Cardiovascular Disorders Ann Intern Med, November 1, 1986; 105(5): 714 - 729. [Abstract] [PDF]